Nomura Asset Management International’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
FCM
LCM
AC
EAM
Nomura Asset Management International's AGIO Position: Q2 2026 in Review
Nomura Asset Management International increased its Agios Pharmaceuticals (AGIO) stake by 41% in Q2 2026, buying an estimated $18.7M and bringing the position to 2,110,809 shares worth $78.3M. The position accounts for 0.12% of the portfolio, ranked #221.
Nomura Asset Management International first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Nomura Asset Management International held 2,110,809 shares of Agios Pharmaceuticals worth $78.3M as of Q2 2026.
- Nomura Asset Management International bought 616,374 Agios Pharmaceuticals shares in Q2 2026, an estimated $18.7M.
- Agios Pharmaceuticals made up 0.12% of Nomura Asset Management International's portfolio in Q2 2026, its #221 holding.
- Nomura Asset Management International first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.